D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
First Commonwealth Financial
FCF
$2.26B
| $1.77M | ﹤0.01% |
121,924
-21,598
| -15% | -$303K |
|
|
HONE
2527
DELISTED
HarborOne Bancorp
HONE
| $1.76M | ﹤0.01% |
160,298
+90,598
| +130% | +$949K |
|
2528
Univest Financial
UVSP
$1.24B
| $1.76M | ﹤0.01% |
65,724
-5,564
| -8% | -$144K |
|
2529
PUT
West Pharmaceutical
WST
$23.5B
| $1.76M | ﹤0.01% |
11,700
-10,000
| -46% | -$1.46M |
|
|
EMWP
2530
DELISTED
Eros Media World PLC
EMWP
| $1.76M | ﹤0.01% |
25,948
-31,004
| -54% | -$1.45M |
|
|
VIA
2531
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $1.76M | ﹤0.01% |
38,069
+18,035
| +90% | +$902K |
|
2532
Harmonic Inc
HLIT
$1.15B
| $1.76M | ﹤0.01% |
225,157
+47,002
| +26% | +$351K |
|
2533
Hancock Whitney
HWC
$6.2B
| $1.75M | ﹤0.01% |
39,995
-38,939
| -49% | -$1.58M |
|
|
VNE
2534
PUT
DELISTED
Veoneer, Inc.
VNE
| $1.75M | ﹤0.01% |
112,100
| – | – |
|
|
WUBA
2535
PUT
DELISTED
58.com Inc
WUBA
| $1.75M | ﹤0.01% |
27,000
| – | – |
|
2536
PUT
Allegiant Air
ALGT
$2.61B
| $1.74M | ﹤0.01% |
+10,000
| New | +$1.66M |
|
2537
PUT
Take-Two Interactive
TTWO
$46.5B
| $1.74M | ﹤0.01% |
+14,200
| New | +$1.73M |
|
|
ALE
2538
DELISTED
Allete
ALE
| $1.74M | ﹤0.01% |
+21,394
| New | +$1.77M |
|
2539
Civeo
CVEO
$365M
| $1.73M | ﹤0.01% |
111,885
-106,831
| -49% | -$1.34M |
|
2540
SLR Investment Corp
SLRC
$714M
| $1.73M | ﹤0.01% |
83,965
+29,701
| +55% | +$610K |
|
|
ESPR
2541
CALL
DELISTED
Esperion Therapeutics
ESPR
| $1.73M | ﹤0.01% |
29,000
| – | – |
|
|
PCH
2542
DELISTED
PotlatchDeltic
PCH
| $1.73M | ﹤0.01% |
+39,963
| New | +$1.71M |
|
2543
Morningstar
MORN
$7.53B
| $1.73M | ﹤0.01% |
11,418
+2,821
| +33% | +$433K |
|
2544
Insteel Industries
IIIN
$601M
| $1.73M | ﹤0.01% |
80,300
-15,836
| -16% | -$335K |
|
|
TUP
2545
PUT
DELISTED
Tupperware Brands Corporation
TUP
| $1.72M | ﹤0.01% |
200,900
-63,000
| -24% | -$687K |
|
2546
PUT
Boston Properties
BXP
$11.8B
| $1.72M | ﹤0.01% |
+12,500
| New | +$1.68M |
|
2547
Urban Edge Properties
UE
$2.93B
| $1.72M | ﹤0.01% |
89,802
-107,726
| -55% | -$2.18M |
|
2548
Vericel Corp
VCEL
$2.36B
| $1.72M | ﹤0.01% |
98,938
-82,146
| -45% | -$1.4M |
|
2549
James Hardie Industries
JHX
$15.1B
| $1.72M | ﹤0.01% |
87,939
+27,864
| +46% | +$517K |
|
|
ITCI
2550
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.72M | ﹤0.01% |
+50,000
| New | +$600K |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.